Tag: hepatitis B

photo of doctors hands holding a digital graphic of a liver

Warminster biotech company Arbutus Biopharma shared promising results from its latest study on a new treatment for hepatitis B, writes John George for the Philadelphia…

Pharma & Biotech

PROTECS Opens Innovation Center in Building Leased to Warminster’s Arbutus Headquarters

February 22, 2024

Life sciences real estate company PROTECS is acquiring a 35,000-square-foot research and development lab facility in Warminster.

The building is the latest…

Pharma & Biotech

Arbutus Biopharma CEO William Collier Announces Retirement As Company Cuts 24 Percent

November 13, 2023

William Collier, president and CEO of Warminster-based Arbutus Biopharma, will retire from his positions effective December 31, writes John George for the Philadelphia Business…

Pharma & Biotech

Doylestown Medical Nonprofit Names Physician, Advocate as Recipient of 2023 Community Commitment Award

January 13, 2023

A major medical nonprofit in Bucks County has just named an influential physician as their recipient for their yearly advocacy award. Staff writers for NewsWires…

Pharma & Biotech

Warminster’s Arbutus Biopharma Strikes Licensing-Partnering Deal with Chinese Pharma Firm

December 20, 2021

Arbutus Biopharma, Warminster, has entered a $300 million licensing and partnership deal with a Chinese biopharmaceutical firm. enters into $300M deal for experimental hepatitis B…

Tag: hepatitis B

Warminster's Arbutus Biopharma Achieves Breakthrough in Hepatitis B Treatment

PROTECS Opens Innovation Center in Building Leased to Warminster’s Arbutus Headquarters

Arbutus Biopharma CEO William Collier Announces Retirement As Company Cuts 24 Percent

Doylestown Medical Nonprofit Names Physician, Advocate as Recipient of 2023 Community Commitment Award

Warminster’s Arbutus Biopharma Strikes Licensing-Partnering Deal with Chinese Pharma Firm